查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1963947

子宮內膜消融術市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、最終用途、地區和競爭對手分類，2021-2031年

Endometrial Ablation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球子宮內膜消融市場預計將從 2025 年的 20.9 億美元成長到 2031 年的 28.7 億美元，年複合成長率為 5.43%。

作為一種微創手術，子宮內膜切除術已成為月經過多女性避免大型手術的重要治療方法。這一市場成長的主要促進因素是醫療服務提供者和患者越來越傾向於保留子宮的治療方案（預計可縮短住院時間和恢復時間），以及全球範圍內異常子宮出血發病率的上升。事實上，美國血液學會指出，2024年約有五分之一的女性受到月經，這顯著提升了對有效治療方法的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 20.9億美元
市場規模：2031年 28.7億美元
複合年成長率：2026-2031年 5.43%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

然而，這些手術的長期療效和術後併發症風險在市場中面臨重大挑戰。阻礙其廣泛應用的主要障礙是治療失敗的可能性，這往往會導致後續需要子宮切除術。因此，醫生在比較消融術的永久性與根治性手術方案時可能會猶豫不決。

市場促進因素

全球子宮內膜消融術市場的主要促進因素是異常子宮出血（AUB）和月經過多的盛行率不斷上升，尤其是在育齡女性族群老化的情況下。隨著女性接近閉經，月經的發生率增加，尋求有效且保留子宮治療的患者群體也不斷擴大。這直接導致手術數量的增加，因為患者傾向於選擇創傷較小的治療方案而非大型手術。發表於2025年3月《澳洲醫學雜誌》的一項研究也印證了這種日益加重的臨床負擔。研究發現，月經過多的盛行率隨年齡顯著增加，48歲女性的盛行率高達32.1%，凸顯了尋找可靠的子宮切除術替代方案的迫切需求。

同時，第二代消融設備的科技進步，特別是高頻和微創系統，正在改變市場格局。這些創新提高了安全性，縮短了恢復時間，加速了其在門診環境中的應用。領先的製造商報告稱，這些產品線帶來了持續的財務成長。例如，2025年2月，Hologic宣布其婦科手術部門的收入達到1.663億美元（成長2.5%），這主要得益於微創解決方案的推動。同樣，2025年5月，Olympus Corporation宣布其治療解決方案部門的收入成長了6.9%，證實了其先進婦科技術的商業性成功不斷擴大。

市場挑戰

全球子宮內膜消融術市場的成長受到長期治療失敗風險的顯著限制。這種風險通常需要二次手術干預，儘管該手術屬於微創手術，但子宮內膜再生的可能性仍可能導致月經復發。這使得臨床醫生和患者對子宮切除術猶豫不決，他們認為子宮切除術是更可靠的永久性解決方案。因此，人們更傾向於選擇一次根治性手術而非效果不穩定的技術，這限制了消融設備的普及。

此外，再次治療帶來的臨床和經濟負擔會對市場潛力產生負面影響。如果患者需要再次手術，那麼最初的益處，例如縮短恢復時間和住院時間，實際上將被抵消。歐洲婦科內視鏡學會2024年的一項縱向分析也支持了這個問題，該分析顯示，約16.5%的女性在首次子宮內膜消融術後五年內接受了子宮切除術，這凸顯了再次手術帶來的重大挑戰，限制了市場的發展。

市場趨勢

重塑產業的一個關鍵趨勢是，手術環境正加速向門診和診所轉移，這主要是由於醫療機構對經濟高效的工作流程的需求日益成長，以減輕其後勤負擔。一次性預組裝便利套裝的開發正積極推動這一轉變，這些套裝簡化了各個部件的採購和消毒流程，使其更易於在非醫院環境中實施。例如，Minerva Surgical 於 2025 年 5 月宣布推出 HERizon™ Hysto-Kit，這是一款全面的單次使用套裝，旨在縮短門診子宮鏡檢查的時間，並確保操作流程的一致性。這直接滿足了在傳統手術室之外提供高效醫療服務日益成長的需求。

同時，作為熱消融療法的替代方案，冷凍消融療法正逐漸興起，其重點在於提高患者舒適度並減少術中麻醉用量。與依賴熱能的射頻消融系統不同，冷凍療法利用極低的溫度破壞子宮內膜，並具有天然的鎮痛效果，因此特別適合在診所進行清醒狀態下的手術。為了支持這項技術的日益普及，ChannelMed Systems公司於2025年11月宣布，其Selene®冷凍治療設備已成功完成超過5,000例手術。這表明，這種治療月經過多的新方法正被越來越多的臨床醫生所接受。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球子宮內膜消融市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品特定方法（冷凍消融、射頻消融術、水熱消融、熱感球消融、微波能等）
    • 依用途（醫院/診所、門診手術中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美子宮內膜消融術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲子宮內膜消融術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區子宮內膜消融術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲子宮內膜消融術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲子宮內膜消融術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球子宮內膜消融市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Boston Scientific
  • Hologic
  • Minerva Surgical
  • CooperSurgical
  • Medtronic
  • Olympus
  • Karl Storz
  • Ethicon
  • Stryker
  • Johnson & Johnson

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21148

The Global Endometrial Ablation Market is projected to expand from USD 2.09 Billion in 2025 to USD 2.87 Billion by 2031, growing at a CAGR of 5.43%. As a minimally invasive surgical procedure utilized to destroy the uterine endometrial lining, it serves as a key treatment for women with menorrhagia who prefer to avoid major surgery. This market growth is primarily fueled by a growing preference among both healthcare providers and patients for uterus-sparing methods that reduce hospital stays and recovery times, alongside a rising global incidence of abnormal uterine bleeding; indeed, the American Society of Hematology noted in 2024 that heavy menstrual bleeding affects roughly one in five females, driving substantial demand for effective interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.09 Billion
Market Size 2031USD 2.87 Billion
CAGR 2026-20315.43%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

However, the market faces significant challenges regarding the long-term efficacy of these procedures and the risk of post-operative complications. A major barrier to wider adoption is the potential for treatment failure, which often leads to the need for subsequent hysterectomies, causing clinicians to hesitate when comparing the permanence of ablation against definitive surgical alternatives.

Market Driver

The primary driver of the global endometrial ablation market is the rising prevalence of abnormal uterine bleeding (AUB) and menorrhagia, especially within the aging reproductive demographic. As women near perimenopause, menstrual irregularities become more frequent, creating a large patient population seeking effective, uterus-sparing treatments, which directly translates into higher procedural volumes as patients choose less invasive options over major surgeries. This increasing clinical burden is highlighted by a study in the Medical Journal of Australia from March 2025, which found that the prevalence of heavy menstrual bleeding rises significantly with age, affecting 32.1% of women at 48 years, thereby reinforcing the urgent need for reliable non-hysterectomy solutions.

Simultaneously, the market is being transformed by technological advancements in second-generation ablation devices, particularly radiofrequency and minimally invasive systems. These innovations provide better safety profiles and shorter recovery times, promoting their adoption in outpatient settings, while leading manufacturers report sustained financial growth linked to these portfolios. For instance, Hologic, Inc. reported in February 2025 that its GYN Surgical division achieved $166.3 million in revenue, a 2.5% increase driven by minimally invasive solutions, and Olympus Corporation announced in May 2025 that its Therapeutic Solutions Division saw a 6.9% revenue rise, confirming the expanding commercial success of advanced gynecological technologies.

Market Challenge

The growth of the Global Endometrial Ablation Market is significantly hindered by the risk of long-term treatment failure, which often necessitates secondary surgical interventions. Although the procedure is valued for being minimally invasive, the potential for endometrial regrowth can lead to the recurrence of heavy menstrual bleeding, causing hesitation among clinicians and patients who may view hysterectomy as a more reliable solution for permanent relief. Consequently, the preference for a one-time curative surgery over a technique with variable durability limits the widespread adoption of ablation devices.

Furthermore, the clinical and economic burden of repeat procedures negatively impacts market potential, as the initial benefits of reduced recovery time and hospital stays are effectively negated when patients require subsequent surgeries. This issue is substantiated by a 2024 longitudinal analysis from the European Society for Gynaecological Endoscopy, which indicated that approximately 16.5% of women underwent a hysterectomy within five years of their initial endometrial ablation, highlighting the significant challenge of re-intervention that restricts the market's trajectory.

Market Trends

A major trend reshaping the industry is the accelerated transition toward ambulatory and office-based surgical settings, driven by the demand for cost-effective, streamlined workflows that reduce logistical burdens on healthcare providers. This shift is actively supported by the development of single-use, pre-assembled convenience kits that remove the complexity of sourcing and sterilizing individual components, thereby facilitating easier adoption in non-hospital environments. Illustrating this operational evolution, Minerva Surgical announced in May 2025 the launch of the HERizon(TM) Hysto-Kit, a comprehensive single-use package designed to save time and ensure procedural consistency for clinicians performing hysteroscopy in outpatient settings, directly addressing the growing demand for efficient care outside the traditional operating room.

In parallel, the market is witnessing the rise of cryoablation solutions as a distinct alternative to heat-based modalities, focusing on enhanced patient comfort and reduced intra-operative anesthesia requirements. Unlike radiofrequency systems that rely on thermal energy, cryotherapy uses extreme cold to destroy the endometrial lining, offering a natural analgesic effect that makes it particularly suitable for awake procedures in office environments. Validating the rising adoption of this technology, Channel Medsystems announced in November 2025 that it had surpassed 5,000 procedures with its Cerene(R) Cryotherapy device, underscoring the expanding clinical acceptance of this novel approach for managing heavy menstrual bleeding.

Key Market Players

  • Boston Scientific
  • Hologic
  • Minerva Surgical
  • CooperSurgical
  • Medtronic
  • Olympus
  • Karl Storz
  • Ethicon
  • Stryker
  • Johnson & Johnson

Report Scope

In this report, the Global Endometrial Ablation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endometrial Ablation Market, By Product

  • Cryoablation
  • Radiofrequency Ablation
  • Hydrothermal Ablation
  • Thermal Balloon
  • Microwave Energy
  • Others

Endometrial Ablation Market, By End Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Endometrial Ablation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Endometrial Ablation Market.

Available Customizations:

Global Endometrial Ablation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endometrial Ablation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Thermal Balloon, Microwave Energy, Others)
    • 5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Endometrial Ablation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Endometrial Ablation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Endometrial Ablation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Endometrial Ablation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Endometrial Ablation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Endometrial Ablation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Endometrial Ablation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Endometrial Ablation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Endometrial Ablation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Endometrial Ablation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Endometrial Ablation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Endometrial Ablation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Endometrial Ablation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Endometrial Ablation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Endometrial Ablation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Endometrial Ablation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Endometrial Ablation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Endometrial Ablation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Endometrial Ablation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Endometrial Ablation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. South America Endometrial Ablation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Endometrial Ablation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Endometrial Ablation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Endometrial Ablation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Endometrial Ablation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hologic
  • 15.3. Minerva Surgical
  • 15.4. CooperSurgical
  • 15.5. Medtronic
  • 15.6. Olympus
  • 15.7. Karl Storz
  • 15.8. Ethicon
  • 15.9. Stryker
  • 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer